(NASDAQ: SHC) Sotera Health Co's forecast annual revenue growth rate of 4.5% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.7%.
Sotera Health Co's revenue in 2025 is $1,100,441,000.On average, 3 Wall Street analysts forecast SHC's revenue for 2025 to be $320,828,325,115, with the lowest SHC revenue forecast at $320,727,408,606, and the highest SHC revenue forecast at $320,988,204,080. On average, 3 Wall Street analysts forecast SHC's revenue for 2026 to be $339,559,393,135, with the lowest SHC revenue forecast at $336,681,288,293, and the highest SHC revenue forecast at $341,613,724,444.
In 2027, SHC is forecast to generate $361,784,270,094 in revenue, with the lowest revenue forecast at $361,343,469,047 and the highest revenue forecast at $362,225,071,141.